Humana Inc. $HUM Stake Lifted by Armistice Capital LLC

Armistice Capital LLC increased its stake in shares of Humana Inc. (NYSE:HUM) by 39.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,697 shares of the insurance provider’s stock after buying an additional 20,338 shares during the quarter. Armistice Capital LLC owned about 0.06% of Humana worth $18,364,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Long Focus Capital Management LLC bought a new stake in shares of Humana during the third quarter valued at approximately $34,212,000. AMG National Trust Bank raised its holdings in shares of Humana by 106.5% during the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock valued at $4,411,000 after buying an additional 8,744 shares during the last quarter. Aberdeen Group plc raised its holdings in shares of Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after buying an additional 43,442 shares during the last quarter. Alberta Investment Management Corp bought a new stake in shares of Humana during the third quarter valued at approximately $4,735,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after buying an additional 9,960 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Trading Down 2.0%

Humana stock opened at $361.95 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The firm has a market cap of $43.46 billion, a price-to-earnings ratio of 38.71, a price-to-earnings-growth ratio of 2.10 and a beta of 0.76. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $380.86. The firm’s 50 day moving average price is $279.36 and its two-hundred day moving average price is $239.95.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, research analysts predict that Humana Inc. will post 9.04 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on HUM shares. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Humana in a report on Thursday, June 11th. Weiss Ratings raised Humana from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, June 12th. Leerink Partners lifted their price target on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a report on Thursday, April 30th. Finally, The Goldman Sachs Group lifted their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $291.35.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.